NantHealth (NH) PT Lowered to $13 at Cantor Fitzgerald Following 4Q
Tweet Send to a Friend
Cantor Fitzgerald lowered its price target on NantHealth (NASDAQ: NH) to $13.00 (from $15.00) while maintaining a Overweight rating. NH ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
